Biotech News

LifeStance Reports Fourth Quarter and Full Year 2025 Results

LifeStance Health (LFST)LifeStance Health2026-06-25 13:46 ESTEarnings

Announces $100 Million Share Repurchase Program SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the fourth quarter and full year ended

Open original release

Related news

LifeStance Health

LifeStance Health is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

Stock data

Close
Market cap
Exchange
NASDAQ
Sector
Biotechnology
Location
United States